Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Propofol-Associated Hypertriglyceridemia in Coronavirus Disease 2019 Versus Noncoronavirus Disease 2019 Acute Respiratory Distress Syndrome
Pharmacology, Disaster, Pulmonary,
From Critical Care Explorations
In this study, the authors found that patients with coronavirus disease 2019 acute respiratory distress syndrome experienced a higher rate of propofol-associated hypertriglyceridemia than noncoronavirus disease 2019 acute respiratory distress syndrome patients, even after accounting for differences in propofol administration.
Kenes MT, McSparron JI, Marshall VD, et al.
Estimated Time: 23:03